• Edit
Get premium to view all results
DateInvestorsAmountRound
-investor

€0.0

round
investor

€0.0

round
investor

€0.0

round

€445k

Seed
Total Funding000k

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
EUR20192020
Revenues00000000
% growth-(94 %)
EBITDA00000000
Profit00000000
EV00000000
EV / revenue00.0x00.0x
EV / EBITDA00.0x00.0x
R&D budget00000000

Source: Company filings or news article

Notes (0)
More about ETISENSE SAS
Made with AI
Edit

Etisense, a French MedTech company, was founded in 2018 as a spin-off from Grenoble University by Timothé Flenet and Charles Eynard.

The founders combined their expertise to address a need in the biomedical research field. Timothé Flenet, a scientist and entrepreneur, serves as the CEO and Scientific Director, while Charles Eynard, with a background in the computer software industry, is the CTO.

Etisense specializes in the development and commercialization of non-invasive physiological monitoring solutions for the preclinical research market. The company's business model is centered on providing researchers with tools that improve data acquisition without compromising animal welfare.

The flagship product, DECRO, is an external telemetry jacket designed for non-invasive monitoring of physiological parameters in laboratory animals. This system allows for the continuous collection of data such as electrocardiogram (ECG), respiration, and activity, without the need for surgical implantation of sensors.

Keywords: MedTech, preclinical research, non-invasive monitoring, physiological data, telemetry jacket, biomedical engineering, animal welfare, data acquisition, scientific instrumentation, life sciences.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo